CHICAGO EQUITY PARTNERS LLC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 204 filers reported holding REGENXBIO INC in Q3 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2019$200,000
-30.6%
5,6050.0%0.01%
-23.1%
Q2 2019$288,000
-57.8%
5,605
-53.0%
0.01%
-50.0%
Q1 2019$683,000
-61.0%
11,915
-71.5%
0.03%
-63.4%
Q4 2018$1,751,000
-61.5%
41,745
-30.7%
0.07%
-47.0%
Q3 2018$4,549,000
+42.4%
60,250
+35.3%
0.13%
+36.7%
Q2 2018$3,195,00044,5260.10%
Other shareholders
REGENXBIO INC shareholders Q3 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 847,424$13,948,59912.64%
Sonic GP LLC 518,079$8,527,5808.28%
MPM BioImpact LLC 656,718$10,809,5782.89%
Redmile Group, LLC 2,574,042$42,368,7312.02%
ArchPoint Investors 224,278$3,691,6161.41%
WS MANAGEMENT LLLP 618,131$10,174,4360.82%
Redwood Wealth Management Group, LLC 14,360$236,3660.28%
HARBOR CAPITAL ADVISORS, INC. 48,559$799,2810.17%
PRENTISS SMITH & CO INC 11,240$185,0100.14%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 36,522$601,1520.09%
View complete list of REGENXBIO INC shareholders